Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
Sales | 26,383 | 20,681 | 17,831 | 16,049 | 13,956 |
Cost of Goods | 22,872 | 20,295 | 18,833 | 17,770 | 19,111 |
Gross Profit | 3,511 | 385 | -1,002 | -1,722 | -5,155 |
Operating Expenses | 17,575 | 15,118 | 15,412 | 14,213 | 12,176 |
Operating Income | -13,191 | -14,437 | -15,581 | -15,164 | -17,220 |
Interest Expense | 3,316 | 3,299 | 3,247 | 3,196 | 3,110 |
Other Income | -143 | 23 | -77 | -20 | 922 |
Pre-tax Income | -16,650 | -17,713 | -18,905 | -18,380 | -19,408 |
Net Income Continuous | -16,650 | -17,713 | -18,905 | -18,380 | -19,408 |
Net Income | $-16,650 | $-17,713 | $-18,905 | $-18,380 | $-19,408 |
EPS Basic Total Ops | -0.07 | -0.13 | -0.15 | -0.16 | -0.20 |
EPS Basic Continuous Ops | -0.07 | -0.13 | -0.15 | -0.16 | -0.19 |
EPS Diluted Total Ops | -0.07 | -0.13 | -0.15 | -0.16 | -0.20 |
EPS Diluted Continuous Ops | -0.07 | -0.13 | -0.15 | -0.16 | -0.19 |
EBITDA(a) | $-11,206 | $-12,565 | $-13,827 | $-13,527 | $-15,585 |